Back

Paradigm Medical Communications, LLC

  • Endothelial Growth Factors

Reading Between the Lines: Nuanced Decision-Making With Sustained Delivery Therapies

Frequent intravitreal anti-vascular endothelial growth factor injections remain a major barrier to optimizing real-world outcomes in patients with retinal vascular disease. Sustained delivery therapies are redefining what is possible in retinal care. Using simulation-enhanced case studies, experts will highlight potential uses of new and emerging sustained delivery innovations, providing retina specialists and other ophthalmologists with realistic strategies for patient selection, safe integration, and long-term management in clinical practice.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AMA PRA Category 1 Credit™Up to 1 credit

MOC types

No MOC

FDA REMS

No

Qualifies for MIPS

No

Target Specialties

Pricing

Free

Reported to ACCME by the provider

  • Enduring / On-demand
  • Credit · Up to 1 credit
  • Commercial Support
  • Released
    Mar 31, 2026
  • Last day to claim credit
    Apr 1, 2027 6 months left